CorDX # ACT21002-1

CorDX ACT21002-1 - TyFast Flu A/B & COVID-19 At Home Multiplex Rapid Test, OTC, 150 Tests Per Case

The CorDX ACT21002-1 TyFast Flu A/B & COVID-19 At Home Multiplex Rapid Test provides an efficient solution for the simultaneous qualitative detection of influenza A, influenza B, and SARS-CoV-2 nucleocapsid protein antigens. Designed for professional healthcare organizations, this multiplex rapid test is a critical tool for rapid diagnostic screening in high-volume clinical settings, supporting timely patient management and infection control protocols.

Product Specifications

• SKU: ACT21002-1
• Brand: CorDX
• Packaging: 150 Tests Per Case
• Application: Multiplex Rapid Test for Flu A/B & COVID-19 Antigen Detection
• Certifications / Standards: OTC
• Availability: In Stock

Key Features

• Multiplex Detection – Simultaneously identifies influenza A, influenza B, and SARS-CoV-2 antigens from a single sample, streamlining diagnostic workflows in healthcare environments.
• Rapid Results – Delivers quick diagnostic outcomes, enabling immediate patient isolation, treatment planning, and effective infection control measures.
• High-Volume Packaging – Supplied in cases of 150 tests, optimizing inventory management and ensuring readiness for sustained institutional demand.
• OTC Classification – Facilitates broader access and deployment within various healthcare settings for efficient screening protocols without prescription requirements.
• Clinical Efficiency – Designed to integrate seamlessly into professional healthcare environments for point-of-care testing, enhancing operational flow and patient throughput.

Suggested Applications

• Initial screening of patients presenting with acute respiratory symptoms in emergency departments and urgent care centers.
• Surveillance and outbreak management protocols in long-term care facilities and correctional institutions.
• Pre-procedural screening in surgery centers and hospitals to mitigate infection risks and maintain sterile environments.
• Rapid diagnosis within laboratory settings to support public health initiatives and epidemiological monitoring.
• Point-of-care testing in primary care clinics to inform immediate patient management and referral decisions.

Industries of Use

Hospitals, Clinics, Surgery Centers, Emergency Medical Services (EMS), Laboratories, Long-Term Care Facilities, and Public Health Agencies.

The CorDX ACT21002-1 TyFast multiplex rapid test offers healthcare procurement managers a reliable and efficient diagnostic solution for managing common respiratory viral infections. Its bulk packaging and rapid results contribute to optimized operational efficiency and effective infection control strategies across diverse professional healthcare settings, ensuring preparedness and swift response capabilities within institutional supply chains.